Brad Heppner founded Beneficient and ran it as chief executive until a federal jury convicted him of fraud this past spring. Now the company wants his debt and equity interests gone. What it is offering him in return is a handful of shares.
According to a press release attached to an 8-K filed with the SEC on September 23, the proposed deal would cancel about $130 million in contested debt held by HCLP Nominees — an entity the company says Heppner secretly controlled and used to fabricate a claim against the company. It would also convert preferred equity with a stated liquidation preference of about $850 million into just 162,132 shares of Class A common stock. A third piece would terminate other agreements and extinguish about $88 million in other amounts the company calls purportedly owed.
For a holder of the stock, two things stand out. Heppner holds Class B shares that carry super-voting, board-appointment, and consent rights — the kind of structural control that leaves other shareholders with limited ability to force change. And the preferred equity represents a potential dilution overhang: a large unconverted claim that, depending on how it is eventually resolved, could produce far more common shares than currently exist. The proposed deal would end both.
Shares closed 438.73% higher at $2.9000 after the announcement, on turnover of about $598 million. The free float stands at about 1.4 million shares.
The company's case rests on the conviction. According to the press release, Heppner was found guilty on May 7, 2026, of securities fraud, wire fraud and related charges. The criminal trial, the company says, produced evidence that he concealed his control of HCLP and fabricated the debt it now claims to be owed. On that basis, the company calls the HCLP debt invalid and unenforceable.
The company says it is trying to complete a consensual deal before Heppner's sentencing, scheduled for October 21, 2026. No definitive agreement has been signed, and the company said in the release there is no assurance one will be reached. If negotiations fail, it says, it is prepared to pursue all available claims and remedies through litigation.
Whether Heppner agrees before October 21, and on what terms, is now the largest single unresolved item on Beneficient's balance sheet.